Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. | Astellas is aiding Vir ...
The New England Patriots have signed Stefon Diggs, but that does not mean their need for a wide receiver has been totally quenched. The Patriots still need more help at the position, especially ...